[1] Writing G M, Mozaffarian D, Benjamin E J, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association [J]. Circulation, 2016, 133(4): e38-e60.
[2] DeVore A D, Hammill B G, Sharma P P, et al. In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization [J]. Journal of the American
Heart Association, 2014, DOI: 10.1161/JAHA.114.001088.
[3] Jaffe M L, Morin D P. Cardiac resynchronization therapy: history, present, status, and future directions [J]. The Ochsner Journal, 2014, 14: 596-607.
[4] Shenkman H J, Pampati V, Khandelwal A K, et al. Congestive heart failure and QRS duration: establishing prognosis study [J]. Chest, 2002, 122(2): 528-534.
[5] Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy [J]. Pacing and Clinical Electrophysiology: PACE, 1994, 17(11Pt2): 1974-1979.
[6] Kass D A, Chen C H, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay [J]. Circulation, 1999, 99(12): 1567-1573.
[7] Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure [J]. Circulation, 1999, 99(23): 2993-3001.
[8] Bax J J, Gorcsan J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective [J]. Journal of the American College of Cardiology, 2009, 53(21): 1933-1943.
[9] Birnie D H, Tang A S. The problem of non-response to cardiac resynchronization therapy [J]. Current Opinion in Cardiology, 2006, 21(1): 20-26.
[10] Kirk J A, Kass D A. Electromechanical dyssynchrony and resynchronization of the failing heart [J]. Circulation Research, 2013, 113(6): 765-776.
[11] Yu C M, Sanderson J E, Gorcsan J. Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy [J]. European Heart Journal, 2010, 31(19): 2326-2337.

[12] Tanaka H, Nesser H J, Buck T, et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study [J]. European Heart Journal, 2010, 31(14): 1690-1700.
[13] Chung E S, Leon A R, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) trial [J]. Circulation, 2008, 117(20): 2608-2616.
[14] Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases [J]. The FEBS Journal, 2011, 278(10): 1619-1633.
[15] Xiao J. MicroRNA therapeutics [J]. Mini Reviews in Medicinal Chemistry, 2015, 15(6): 440.
[16] Zhou L, Zang G, Zhang G, et al. MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation [J]. PLoS One, 2013, 8(11): e79805.
[17] Mendell J T, Olson E N. MicroRNAs in stress signaling and human disease [J]. Cell, 2012, 148(6): 1172-1187.
[18] Marfella R, Di Filippo C, Potenza N, et al. Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders [J].
European Journal of Heart Failure, 2013, 15(11): 1277-1288.
[19] Melman Y F, Shah R, Danielson K, et al. Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: a translational pilot study [J]. Circulation, 2015, 131(25): 2202-2216.